-
WuXi Biologics Completes First FDA Routine GMP Inspection
contractpharma
May 16, 2019
Production of Trogarzo is now approved at the Wuxi facility.
-
Harbour BioMed, Chia Tai Tianqing Enter Biologics Partnership
contractpharma
May 16, 2019
Global collaboration focused on new antibody treatments in the fields of oncology and immunology.
-
Mallinckrodt Completes Wisconsin Mfg. Facility
contractpharma
April 26, 2019
Mallinckrodt has completed the expansion of its operations and manufacturing facility for the investigational StrataGraft regenerative skin tissue, in Madison, WI. Stratatech, a Mallinckrodt company ...
-
AGC Biologics CEO to Step Down
contractpharma
April 09, 2019
AGC Biologics CEO to Step Down
-
Ajinomoto Appoints VP of Sales & Marketing
pharmatimes
April 04, 2019
Ajinomoto Bio-Pharma Services, a global provider of bio-pharmaceutical contract development and manufacturing services, has appointed Jean-Baptiste Agnus as vice president of sales and marketing.
-
The AveXis expands world-leading gene therapy manufacturing capacity with purchase of advanced biologics therapy manufacturing campus in Longmont, Colorado
worldpharmanews
April 02, 2019
AveXis further expanding AveXis' production capacity as it prepares to launch Zolgensma®...
-
Envigo Launches PATHWAY
contractpharma
March 13, 2019
Envigo has launched PATHWAY, an integrated solution designed to optimize non-clinical safety assessment programs to enable first-in-human clinical trials.
-
Fujifilm grabs Biogen biologics plant in Europe to bolster its CDMO business
fiercepharma
March 13, 2019
Biogen will open brand-new biologics facilities in Switzerland and has decided it no longer needs its older operations in Denmark.
-
FDA accepts Roche's supplemental biologics license application for Tecentriq plus chemotherapy (Abraxane and carboplatin)
worldpharmanews
January 22, 2019
Roche announced that the US Food and Drug Administration has accepted the company's supplemental Biologics License Application for Tecentriq
-
AZ appoints controversial doctor to lead new oncology unit
pharmaphorum
January 09, 2019
AstraZeneca has a new and controversial oncology head after the departure of two key leaders led to a management reshuffle....